Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03501602
Other study ID # 2018/77
Secondary ID
Status Recruiting
Phase N/A
First received April 10, 2018
Last updated April 17, 2018
Start date April 5, 2018
Est. completion date July 5, 2019

Study information

Verified date April 2018
Source Kocaeli Derince Education and Research Hospital
Contact Asli D Aydas, Doctor
Phone +905058349312
Email aduyguaydas@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Investigators aimed to compare the ease of use of the LMA protector and I-gel LMA for tracheal intubation with the Aintree catheter in our study.

Laryngeal mask airway (LMA) protector is the second generation perilaryngeal seal type supraglottic airway tool. The I-gel LMA is the second generation uncuffed supraglottic airway device. The Aintree Intubation Catheter has been designed for assisted fiberoptic intubation and for uncomplicated, atraumatic endotracheal tube exchange.Both LMA types have a structure that permits endotracheal intubation. In cases of difficult intubation, these two LMA types can be used. In the literature, there is no study comparing these two LMA types using Aintree catheter.Difficult Airway Society (DAS) published a guide for tracheal intubation in 2011 using Aintree. According to this guide, LMA type LMA Supreme is the most unfavorable for this process. However, there is no research or recommendation on the type of LMA most suitable for use in the literature. In accordance with the data of this study, it will be tried to show which LMA type may be suitable for intubation with Aintree catheter in patients.


Description:

Investigators will include adult patients over 18 years of age who will undergo a surgical operation requiring intubation. Patients will be divided into protector LMA and I-gel LMA groups by closed envelope method. Forty patients are planned for both groups. The age, weight, height, body mass index (BMI) of the patients, operation to be performed, ASA, mallampati, thyromental distance values will be recorded. A standard induction of anesthesia will be applied to the patient. After 2 minutes the LMA will be inserted. It will be recorded how many numbered LMAs are used, success rate, number of trials, optimization maneuver required. With LMA, whether sufficient amount of tidal volume can be given to the patient and whether sufficient amount of chest departure is observed during ventilation will be recorded together with tidal volume values. In patients with adequate ventilation, an Aintree catheter placed on a fiberoptic bronchoscope in LMA will be delivered. Fiberoptic laryngeal appearance staging will be performed:

Stage 4: only the cords look Stage 3: cords + posterior epiglot seen Stage 2: cords + anterior epiglot seen Stage 1: no cords seen Cord vocals will be seen on the monitor and the aintree catheter will be sent into the trachea. After insertion of the trachea, the fiberoptic bronchoscope and LMA are removed and the patient's intubation tube is advanced through the Aintree catheter in the appropriate size and the tube is placed in the trachea. Once participants have made sure that the tube is trachea, it will be removed. The time from insertion of the LMA to placement of the endotracheal tube will be coded. During the procedure, the patient's blood pressure, heart rate, oxygen saturation, any complications that may develop will be recorded.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date July 5, 2019
Est. primary completion date April 5, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Be intubated in surgical operation requiring intubation

- over 18 years old

Exclusion Criteria:

- Difficult intubation story

- Difficult intubation risk

- Presence of gastric reflux

Study Design


Related Conditions & MeSH terms


Intervention

Device:
LMA protector
In this arm the LMA protector will be inserted. The time from took the LMA to placement of the LMA will be recorded. In patients with adequate ventilation, an Aintree catheter placed on a fiberoptic bronchoscope in LMA will be delivered. Cord vocals will be seen on the monitor and the aintree catheter will be sent into the trachea. After the insertion of the trachea, the fiberoptic bronchoscope and LMA are removed and the patient's intubation tube is advanced through the Aintree catheter to the patient's trachea. Once you have made sure that the tube is in the trachea, it will be removed. The time from insertion of the LMA to placement of the endotracheal tube will be recorded.
I-gel LMA
In this arm the I-gel LMA will be inserted. The time from took the LMA to placement of the LMA will be recorded. In patients with adequate ventilation, an Aintree catheter placed on a fiberoptic bronchoscope in LMA will be delivered. Cord vocals will be seen on the monitor and the aintree catheter will be sent into the trachea. After the insertion of the trachea, the fiberoptic bronchoscope and LMA are removed and the patient's intubation tube is advanced through the Aintree catheter to the patient's trachea. Once you have made sure that the tube is in the trachea, it will be removed. The time from insertion of the LMA to placement of the endotracheal tube will be recorded.

Locations

Country Name City State
Turkey Asli Duygu Aydas Kocaeli Derince

Sponsors (1)

Lead Sponsor Collaborator
Kocaeli Derince Education and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Other Mouth openness measuring the maximum openness the patient can open his mouth Up to 10 minutes
Other thiromental distance The distance between the lowest end of the jaw and the thyroid overhang when the head is in full extension. Up to 10 minutes
Other pre-induction systolic and diastolic pulse pre-induction systolic and diastolic pulse rate measurement Up to 10 minutes
Other pre-induction heart rate pre-induction heart rate measurement Up to 10 minutes
Other pre-induction oxygen saturation pre-induction oxygen saturation measurement Up to 10 minutes
Other systolic and diastolic pulse after LMA insertion systolic and diastolic pulse rate measurement after LMA insertion Up to 10 minutes
Other heart rate after LMA insertion heart rate measurement after LMA insertion Up to 10 minutes
Other oxygen saturation after LMA insertion oxygen saturation measurement after LMA insertion Up to 10 minutes
Other systolic and diastolic pulse after intubation systolic and diastolic pulse rate measurement after intubation Up to 10 minutes
Other heart rate after after intubation heart rate measurement after intubation Up to 10 minutes
Other oxygen saturation after intubation oxygen saturation measurement after intubation Up to 10 minutes
Other end tidal carbon dioxide after LMA insertion end tidal carbon dioxide measurement after LMA insertion Up to 10 minutes
Other end tidal carbon dioxide after intubation end tidal carbon dioxide measurement after intubation Up to 10 minutes
Primary Time to Successful Tracheal Intubation This measure of time begins with the handling of the supraglottic device to confirming the appropriate placement of the device by noting the presences of end tidal carbon dioxide. Up to 10 minutes
Secondary Time to Placement of the Supra Glottic Device This measure of time begins with the handling of the supra glottic device to confirming the appropriate placement of the device by noting the presences of end tidal carbon dioxide Up to 10 minutes
Secondary Time to Placement of the Aintree Airway Intubation Catheter This measure of time begins with the handling of the fiberscope to withdrawal of the fiberscope from the Aintree and setting the fiberscope down Up to 10 minutes
Secondary Laryngeal appearance staging Stage 4: only the cords look Stage 3: cords + posterior epiglot seen Stage 2: cords + anterior epiglot seen Stage 1: no cords seen Up to 10 minutes
See also
  Status Clinical Trial Phase
Completed NCT03604120 - Preoxygenation for Difficult Airway Management N/A
Completed NCT04356547 - Orotracheal Intubation Using Flexible Fibro Bronchoscope With vs Without Supraglottic Device N/A
Completed NCT03645174 - Long Endotracheal Tube vs. Aintree Intubating Catheter for Fiberoptic-guided Intubation in Manikin N/A
Completed NCT03578601 - Predictive Parameters for Difficult Tracheal Intubation Identification in Thyroid Surgery
Completed NCT04578119 - Optimal Intubating Technique Using Videolaryngoscopy in Patients With Semi-rigid Neck Collar N/A
Terminated NCT03340207 - Novel Airway Device to Aid Endotracheal Intubations N/A
Completed NCT04091568 - Patient Experience Following Awake Fibreoptic Intubation Compared to Asleep Fibreoptic Intubation
Completed NCT03337555 - A Comparison of McGrath MAC®, Pentax-AWS® and Macintosh Direct Laryngoscopes for Nasotracheal Intubation N/A
Completed NCT04153357 - Comparison of Different Video Laryngoscopes in < 1 Year Old Undergoing Neurosurgical Operations: a Prospective Randomized Study N/A
Recruiting NCT03366311 - TCHCCT-Zhong-Xing-Emergency-Department-airway N/A
Completed NCT03719638 - Comparison of Two Blades of Videolaryngoscope in Simulated Difficult Airway in Children N/A
Completed NCT03716466 - Evaluation of Prophylactic Endotracheal Intubation
Recruiting NCT03514745 - Comparison of Lighted Stylet and GlideScope for Double-lumen Endobronchial Intubation N/A
Completed NCT03118622 - Pentax Videolaryngoscopy in Children N/A
Completed NCT03173443 - Insertion Time Over Fiberoptic Bronchoscope of Double Lumen Tube and Single Lumen Tube N/A
Completed NCT03576352 - Emergency Front of the NecK Access (eFONA) in Children N/A
Completed NCT04457453 - Comparison of Direct and Video Laryngoscope During Endotracheal Intubation in Sellick and Trendelenburg Position N/A
Not yet recruiting NCT04770077 - Sniper Intubation for Training of Undergraduate Medical Student
Completed NCT04779528 - Awake Nasal Fiber-optic Intubation of Severely Obese Patients in Lateral Position N/A
Completed NCT04959149 - Face-to-face Intubation in Morbidly Obese N/A